![Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial - The Lancet Diabetes & Endocrinology Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial - The Lancet Diabetes & Endocrinology](https://www.thelancet.com/cms/attachment/2116720242/2085077274/gr1.gif)
Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial - The Lancet Diabetes & Endocrinology
![URSPRUNG DES WUNDERMITTELS SYNERGISMUS VON METFORMIN UND NATRIUMBUTYRAT. - PCP Pharma S.A. Deutschland URSPRUNG DES WUNDERMITTELS SYNERGISMUS VON METFORMIN UND NATRIUMBUTYRAT. - PCP Pharma S.A. Deutschland](https://pcppharma.de/wp-content/uploads/2022/02/abbildung1.jpg)
URSPRUNG DES WUNDERMITTELS SYNERGISMUS VON METFORMIN UND NATRIUMBUTYRAT. - PCP Pharma S.A. Deutschland
![The use of metformin as an add-on therapy to insulin in the treatment of poorly controlled type 1 diabetes mellitus in adolescents - ScienceDirect The use of metformin as an add-on therapy to insulin in the treatment of poorly controlled type 1 diabetes mellitus in adolescents - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2589936821000049-gr4.jpg)